GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Debt-to-Asset

Gubra AS (OCSE:GUBRA) Debt-to-Asset : 0.11 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Debt-to-Asset?

Gubra AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr10.8 Mil. Gubra AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr60.7 Mil. Gubra AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was kr625.3 Mil. Gubra AS's debt to asset for the quarter that ended in Dec. 2023 was 0.11.


Gubra AS Debt-to-Asset Historical Data

The historical data trend for Gubra AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Debt-to-Asset Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
0.34 0.30 0.17 0.26 0.11

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial 0.17 - 0.26 0.12 0.11

Competitive Comparison of Gubra AS's Debt-to-Asset

For the Biotechnology subindustry, Gubra AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Gubra AS's Debt-to-Asset falls into.



Gubra AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Gubra AS's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(10.75 + 60.685) / 625.28
=0.11

Gubra AS's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(10.75 + 60.685) / 625.28
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS  (OCSE:GUBRA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Gubra AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Gubra AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines